HLA class-I-peptide stability mediates CD8+ T cell immunodominance hierarchies and facilitates HLA-associated immune control of HIV
Author(s)
Kaseke, Clarety; Park, Ryan J; Singh, Nishant K; Koundakjian, Dylan; Bashirova, Arman; Garcia Beltran, Wilfredo F; Takou Mbah, Overbeck C; Ma, Jiaqi; Senjobe, Fernando; Urbach, Jonathan M; Nathan, Anusha; Rossin, Elizabeth J; Tano-Menka, Rhoda; Khatri, Ashok; Piechocka-Trocha, Alicja; Waring, Michael T; Birnbaum, Michael E; Baker, Brian M; Carrington, Mary; Walker, Bruce D; Gaiha, Gaurav D; ... Show more Show less
DownloadPublished version (3.692Mb)
Publisher with Creative Commons License
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Defining factors that govern CD8+ T cell immunodominance is critical for the rational design of vaccines for viral pathogens. Here, we assess the contribution of human leukocyte antigen (HLA) class-I-peptide stability for 186 optimal HIV epitopes across 18 HLA alleles using transporter associated with antigen processing (TAP)-deficient mono-allelic HLA-expressing cell lines. We find that immunodominant HIV epitopes increase surface stabilization of HLA class-I molecules in comparison to subdominant epitopes. HLA class-I-peptide stability is also strongly correlated with overall immunodominance hierarchies, particularly for epitopes from high-abundance proteins (e.g., Gag). Moreover, HLA alleles associated with HIV protection are preferentially stabilized by epitopes derived from topologically important viral regions at a greater frequency than neutral and risk alleles. These findings indicate that relative stabilization of HLA class-I is a key factor for CD8+ T cell epitope immunodominance hierarchies, with implications for HIV control and the design of T-cell-based vaccines.
Date issued
2021-07Department
Koch Institute for Integrative Cancer Research at MIT; Ragon Institute of MGH, MIT and Harvard; Massachusetts Institute of Technology. Department of Biological Engineering; Massachusetts Institute of Technology. Institute for Medical Engineering & Science; Massachusetts Institute of Technology. Department of BiologyJournal
Cell Reports
Publisher
Elsevier BV